Stable expression of HIV-1 MPER extended epitope on the surface of the recombinant probiotic bacteria Escherichia Coli Nissle 1917 using CRISPR/Cas9

Mucosal vaccines have the potential to induce protective immune responses at the sites of infection. Applying CRISPR/Cas9 editing, we aimed to develop a probiotic-based vaccine candidate expressing the HIV-1 e...

Source: Microbial Cell Factories - February 4, 2024 Category: Microbiology Authors: Nathaniel Ninyio, Katherina Schmitt, Gladys Sergon, Charlotta Nilsson, S ören Andersson and Nikolai Scherbak Tags: Research Source Type: research